Get the Stockscreener App
573.07
1.16%
6.57
After Hours:
572.96
-0.11
-0.02%
Idexx Laboratories Inc stock is traded at $573.07, with a volume of 887.78K.
It is up +1.16% in the last 24 hours and up +7.86% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$566.50
Open:
$568.9
24h Volume:
887.78K
Relative Volume:
1.50
Market Cap:
$46.09B
Revenue:
$3.93B
Net Income/Loss:
$894.97M
P/E Ratio:
52.96
EPS:
10.82
Net Cash Flow:
$837.70M
1W Performance:
+7.72%
1M Performance:
+7.86%
6M Performance:
+36.85%
1Y Performance:
+21.25%
1-Day Range:
$567.04
$575.35
1-Week Range:
$537.52
$575.35
52-Week Range:
$356.14
$575.35
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
573.07 | 45.56B | 3.93B | 894.97M | 837.70M | 10.82 |
|
TMO
Thermo Fisher Scientific Inc
|
482.16 | 183.07B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
206.85 | 145.32B | 24.01B | 3.41B | 4.86B | 4.70 |
|
A
Agilent Technologies Inc
|
119.84 | 33.96B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
194.55 | 33.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Why IDEXX Laboratories Inc. stock attracts strong analyst attentionDaily Stock Market Swing Alerts Highlight Key Movers - metal.it
What drove IDEXX's operating profit growth in Q3 2024? - AInvest
How high can IDEXX Laboratories Inc. stock price go in 2025Market Surge Signal for Swing Traders Triggered - metal.it
RSI Crosses Above 30 for IDEXX Laboratories Inc. — Reversal in SightCapital Protection Trading Strategies Gain Interest - metal.it
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
IDEXX Laboratories (IDXX) Rallied in Q2. Here’s Why - Insider Monkey
IDEXX to Release Q2 Earnings: What's in Store for the Stock? - TradingView
What makes IDEXX Laboratories Inc. stock price move sharplyCapitalize on emerging investment opportunities - jammulinksnews.com
What is the risk reward ratio of investing in IDEXX Laboratories Inc. stockUnstoppable trading performance - jammulinksnews.com
What is IDEXX Laboratories Inc. company’s growth strategyAchieve superior returns through strategic trading - jammulinksnews.com
How volatile is IDEXX Laboratories Inc. stock compared to the marketLightning-fast growth - jammulinksnews.com
IDEXX Laboratories Inc: Riding Strong on Robust Financials and Growth Potential - AInvest
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - MSN
Is IDEXX Laboratories Inc. a good long term investmentSuperior trading gains - PrintWeekIndia
What analysts say about IDEXX Laboratories Inc. stockHigh-yield investments - Autocar Professional
IDEXX Laboratories Inc. Stock Analysis and ForecastUnstoppable profit momentum - Autocar Professional
What drives IDEXX Laboratories Inc. stock priceExplosive capital gains - Autocar Professional
Idexx Laboratories stock hits 52-week high at 549.81 USD By Investing.com - Investing.com South Africa
Idexx Laboratories stock hits 52-week high at 549.81 USD - Investing.com
At US$532, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely? - simplywall.st
Should You Consider Adding IDEXX Laboratories (IDXX) to Your Portfolio? - Insider Monkey
IDEXX Laboratories Inc. Surges to 413th in Trading Volume with $253 Million in Shares Traded - AInvest
Here's What to Expect From IDEXX Laboratories' Next Earnings Report - MSN
Agree To Buy Idexx Laboratories At $490, Earn 9.8% Annualized Using Options - Nasdaq
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, Leerink Partners Analyst Says - MarketBeat
Leerink Partners Raises IDXX Price Target to $600, Maintains 'Outperform' Rating - AInvest
Idexx Laboratories Price Target Raised to $600 by Leerink Analyst - AInvest
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $600 - 富途牛牛
Expert Outlook: IDEXX Laboratories Through The Eyes Of 6 Analysts - 富途牛牛
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):